Calithera Biosciences Total Current Liabilities

Calithera Biosciences (CALA) currently reports a total current liabilities of $7.4M as of December 2022. That compares with $14M in the prior-year period — down 47.2% year over year. Use the charts on this page to explore Calithera Biosciences's total current liabilities history and peer comparisons.

Calithera Biosciences's total current liabilities decreased from $14M to $7.4M — a 47.2% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calithera Biosciences reported $7.4M in total current liabilities as of December 2022. That compares with $14M in the prior-year period — down 47.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $7.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calithera Biosciences, and consider following CALA for alerts when major investors trade the stock.

Calithera Biosciences is classified in the Healthcare sector. On total current liabilities, it currently shows $7.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALA with unrelated industries.